Clinical Handbook of Interstitial Lung Disease

The 2nd Edition of The Clinical Handbook of Interstitial Lung Disease is an update of the 1st Edition and provides a comprehensive guide for practicing physicians and other health care providers who are involved in the diagnosis and management of diverse forms of Interstitial Lung Disease (ILD). Key global opinion leaders in respiratory medicine have drawn on their knowledge and experience to generate an authoritative, comprehensive, and concise guidebook for use in clinical settings and clinical research.
This book:

• Offers clear guidance and practical tips for clinicians.
• Provides detailed explanations of the biologic underpinnings and main therapeutic options for each individual type of ILD.
• Contains high-quality radiology and histopathology images of both common and rare forms of ILD.
• Presents state-of-the-art diagnostic and disease management algorithms along with current decision-making guidelines to help navigate clinicians who care for patients with ILD.
• Discusses important topics such as genetic counseling, critical care for disease exacerbations, lung transplantation, and palliative care.

List of contents

1 AN OVERVIEW OF CURRENT APPROACHES AND EMERGING CONCEPTS IN INTERSTITIAL LUNG DISEASE
2 HISTOPATHOLOGY OF INTERSTITIAL LUNG DISEASE: A PATTERN-BASED APPROACH AND EVOLVING CONCEPTS
3 Using thoracic imaging to diagnose ILD
4 THE MULTI-OMIC ETIOLOGY OF IDIOPATHIC PULMONARY FIBROSIS
5 Clinical evaluation of the patient with suspected ILD
6 General principles of ILD diagnosis and management
7 Idiopathic pulmonary fibrosis: Epidemiology, natural history, and pathophysiology
8 Management of Idiopathic Pulmonary Fibrosis
9 Idiopathic interstitial pneumonias other than idiopathic pulmonary fibrosis
10 Pulmonary Hypertension due to Interstitial Lung Disease
11 Hypersensitivity pneumonitis
12 Sarcoidosis
13 Eosinophilic Interstitial Lung Disorders
14 Interstitial Lung Disease Associated with Systemic Autoimmune Rheumatic Diseases
15 Smoking and Interstitial Lung Disease
16 Drug-induced and iatrogenic interstitial lung disease
17 Occupation-related ILD
18 Pulmonary vasculitis and alveolar haemorrhage syndromes
19 Lymphangioleiomyomatosis and Other Cystic Interstitial Lung diseases
20 Cough in idiopathic pulmonary fibrosis and interstitial lung disease
21 Rare Forms of Interstitial Lung Disease
22 Childhood ILD
23 Understanding the role of co-morbidities in interstitial lung diseases.
24 Transplantation for ILD
25 Diagnosis and Management of Critical Illness in Patients with Interstitial Lung Disease
26 Emerging concepts in ILD: a glance into the future.
27 Clinical Trials in Fibrotic ILD

About the author

Dr. Keith Meyer is an internationally recognized expert in advanced lung disease and lung transplantation. After serving in the US Navy during the Vietnam War (1968-1974), he earned Bachelor and Master degrees at the University of Wisconsin-Milwaukee. He then earned his medical degree from the University of Wisconsin-Madison where he subsequently completed a residency and chief residency in internal medicine and a fellowship in pulmonary and critical care medicine. He joined the medical faculty at UW-Madison in 1988 where he was a physician-scientist and tenured professor. Professor Meyer performed basic and clinical research in interstitial lung disease, sarcoidosis, pulmonary infections, lung immunology, cystic fibrosis, and lung ageing. He served as Medical Director of the Interstitial Lung Disease Clinic, Medical Director of the UW Lung Transplant Program, and Director of the Adult Cystic Fibrosis Program at UW. Dr. Meyer authored over 300 published manuscripts and book chapters, served as a principal investigator for over 50 clinical trials, and edited numerous books on various forms of lung disease. Dr. Meyer is a Fellow of the American College of Chest Physicians (ACCP) and the American College of Physicians (ACP). He is currently Professor of Medicine (Emeritus) and Honorary Fellow at UW-Madison.
Muhunthan Thillai, BA, MBBS, MRCP, PhD is Consultant Physician specialising in Interstitial Lung Diseases at the Royal Papworth Hospital in Cambridge, UK. He graduated from St. Mary's Medical School in London 2002 with his medical degree and a BA in medical journalism. He began his training as a junior doctor in London and Oxford where he gained Membership of the Royal College of Physicians. He was then appointed as the Infectious Diseases Fellow on the Map of Medicine project at NHS Connecting for Health and as Editor-in-Chief of Junior Dr magazine, before being awarded a personal Research Training Fellowship from the Wellcome Trust. This allowed him to undertake three years of scientific research into sarcoidosis which culminated in a PhD in Immunology and Proteomics from Imperial College London. He continued his medical training in lung cancer, pulmonary vascular disorders and lung transplantation in Cambridge before being appointed as a consultant Physician in 2014.
Dr. Steve Nathan is an internationally recognized expert in advanced lung diseases, including pulmonary fibrosis and pulmonary hypertension (PH) associated with chronic lung diseases. He currently is the Schar Chair of the Advanced Lung Disease and Lung Transplant Program at Inova Fairfax Hospital in Falls Church, VA. Dr. Nathan received his medical degree from the University of the Witwatersrand Medical School in Johannesburg, South Africa. He subsequently completed a Residency in Internal Medicine at Long Island Jewish Hospital in New York and Fellowships in Pulmonary and Critical Care Medicine and Lung Transplantation at Cedars-Sinai Medical Center in Los Angeles, CA. He has been at Inova Fairfax Hospital since 1996. In addition to his role in patient care, Dr. Nathan is a Professor at the University of Virginia and a prolific researcher who has authored more than 500 publications, including original research manuscripts, reviews, book chapters, and books on idiopathic pulmonary fibrosis (IPF). He serves as a reviewer for several medical journals and is on the editorial board for the journal Thorax. He co-chaired the 6th World Symposium on Pulmonary Hypertension Task Force for Group 3 PH in 2018 and is the current Chair of the Group 3 PH Committee for the Pulmonary Vascular Research Institute's International Drug Development Institute. He has also served on multiple committees for clinical trials in IPF and PH and has been on multiple US Food and Drug Administration advisory boards. Additionally, he is a Fellow of the American College of Chest Physicians (CHEST) and received the 2023 CHEST College Medal Award for meritorious service in advancing chest disease research and treatment.

Product details

• Assisted by: Meyer Keith C. (Editor), Nathan Steven D. (Editor), Thillai Muhunthan (Editor)
• Publisher: Taylor and Francis
• Languages: English
• Product format: Paperback / Softback
• Release: 27.05.2026
• EAN: 9781032587318
• ISBN: 978-1-032-58731-8
• No. of pages: 528
• Weight: 453 g
• Illustrations: schwarz-weiss Illustrationen, farbige Illustrationen, Raster,schwarz-weiss, Raster, farbig, Zeichnungen, schwarz-weiss, Zeichnungen, farbig, Tabellen, schwarz-weiss
• Subjects: Natural sciences, medicine, IT, technology > Medicine > Non-clinical medicine; MEDICAL / General, Radiology, MEDICAL / Critical Care, MEDICAL / Pulmonary & Thoracic Medicine, MEDICAL / Radiology, Radiotherapy & Nuclear Medicine, Respiratory medicine, Anaesthetics, Critical care surgery, Medical imaging: radiology